Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neurodegeneration biomarkers and longitudinal studies

Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation.

Per Kristian Eide; Aslan Lashkarivand; Are Hugo Pripp; Lars Magnus Valnes; Markus Hovd; Geir Ringstad; Kaj Blennow; Henrik Zetterberg

Originally published in Brain communications · 2023-12-12

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Acute sleep deprivation has been shown to affect cerebrospinal fluid and plasma concentrations of biomarkers associated with neurodegeneration, though the mechanistic underpinnings remain unknown. This study compared individuals who, for one night, were either subject to total sleep deprivation or free sleep, (i) examining plasma concentrations of neurodegeneration biomarkers the morning after sleep deprivation or free sleep and (ii) determining how overnight changes in biomarkers plasma concentrations correlate with indices of meningeal lymphatic and glymphatic clearance functions. Plasma concentrations of amyloid-β 40 and 42, phosphorylated tau peptide 181, glial fibrillary acid protein and neurofilament light were measured longitudinally in subjects who from Day 1 to Day 2 either underwent total sleep deprivation ( n = 7) or were allowed free sleep ( n = 21). The magnetic resonance imaging contrast agent gadobutrol was injected intrathecally, serving as a cerebrospinal fluid tracer.

Discussion

The present results address possible mechanisms by which sleep and sleep deprivation affect plasma concentrations of neurodegeneration biomarkers. Reduced plasma concentrations of Aβ40 and Aβ42 after one night of acute sleep deprivation could be caused by impaired meningeal lymphatic clearance capacity of Aβ40 and Aβ42. The overnight change in plasma concentrations of Aβ40 and Aβ42 correlated with indices of meningeal lymphatic clearance capacity in sleeping, but not sleep-deprived, subjects. Plasma concentrations of P-Tau181, GFAP and NfL remained unchanged after sleep deprivation.

Conclusion

In conclusion, the present results highlight the diverse mechanisms by which sleep deprivation changes plasma concentrations of neurodegeneration biomarkers. The results suggest impaired meningeal lymphatic clearance function behind reduced Aβ40 and Aβ42 plasma concentrations after sleep deprivation. Impaired glymphatic function caused by sleep deprivation seemed important for the overnight increase in P-Tau181 plasma concentration. Finally, the effects of acute sleep deprivation on plasma concentrations of GFAP and NfL were minor; clearance of GFAP showed some association with meningeal clearance function.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?